Charles Schwab Investment Management Inc. Buys 270,223 Shares of Oscar Health, Inc. (NYSE:OSCR)

Charles Schwab Investment Management Inc. lifted its stake in Oscar Health, Inc. (NYSE:OSCR) by 20.3% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,600,166 shares of the company’s stock after purchasing an additional 270,223 shares during the period. Charles Schwab Investment Management Inc. owned 0.66% of Oscar Health worth $33,940,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in OSCR. Point72 Hong Kong Ltd bought a new position in shares of Oscar Health in the 2nd quarter worth $78,000. Quest Partners LLC bought a new position in shares of Oscar Health in the 2nd quarter worth $93,000. KBC Group NV boosted its position in shares of Oscar Health by 41.2% in the 3rd quarter. KBC Group NV now owns 4,552 shares of the company’s stock worth $97,000 after purchasing an additional 1,328 shares during the last quarter. Amalgamated Bank boosted its position in shares of Oscar Health by 27.7% in the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after purchasing an additional 1,458 shares during the last quarter. Finally, Optimum Investment Advisors bought a new position in shares of Oscar Health in the 3rd quarter worth $142,000. 75.70% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on OSCR. UBS Group began coverage on Oscar Health in a research report on Monday, October 7th. They issued a “neutral” rating and a $23.00 price target on the stock. Piper Sandler reiterated an “overweight” rating and set a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th. Finally, Bank of America lowered Oscar Health from a “neutral” rating to an “underperform” rating and reduced their target price for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. One analyst has rated the stock with a sell rating, two have issued a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $22.93.

Oscar Health Stock Performance

Shares of Oscar Health stock opened at $17.99 on Wednesday. The firm has a market cap of $4.45 billion, a price-to-earnings ratio of -299.78 and a beta of 1.63. The stock’s 50-day moving average is $17.25 and its 200-day moving average is $17.97. Oscar Health, Inc. has a one year low of $7.50 and a one year high of $23.79. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). The firm had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business’s revenue for the quarter was up 68.3% on a year-over-year basis. During the same quarter last year, the firm earned ($0.29) earnings per share. Equities analysts predict that Oscar Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Insider Activity

In other Oscar Health news, CAO Victoria Baltrus sold 8,078 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $146,050.24. Following the transaction, the chief accounting officer now owns 146,036 shares of the company’s stock, valued at $2,640,330.88. The trade was a 5.24 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Alessandrea C. Quane sold 16,793 shares of the business’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $17.06, for a total value of $286,488.58. Following the transaction, the executive vice president now directly owns 392,607 shares in the company, valued at approximately $6,697,875.42. This trade represents a 4.10 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have bought 1,055,478 shares of company stock worth $14,432,852 and have sold 150,360 shares worth $2,645,074. Corporate insiders own 25.11% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.